What are the characteristics of Gram-positive (Gram+) bacteria that form clusters and chains?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Gram-positive bacteria that form clusters, such as Staphylococcus aureus, can be identified through Gram staining and have significant clinical implications, including the potential to cause skin infections, pneumonia, and toxic shock syndrome, and thus, proper identification and treatment with appropriate antibiotics, such as penicillins, cephalosporins, or vancomycin, is crucial 1. When examining Gram-positive bacteria, it is essential to consider their morphological arrangements, as these can provide valuable diagnostic clues. Staphylococci, which include S. aureus, typically arrange in grape-like clusters, while streptococci, such as Streptococcus pyogenes (Group A Strep) and Streptococcus pneumoniae, form chains of varying lengths.

  • The arrangement patterns of these bacteria result from their cell division processes, with staphylococci dividing in multiple planes to create clusters, and streptococci dividing in a single plane to form chains.
  • The identification of these bacteria through Gram staining and culture is critical for effective treatment, as their arrangement patterns can help guide appropriate antimicrobial therapy.
  • In the case of S. aureus, the use of Gram staining morphology can be useful in predicting ventilator-associated pneumonia (VAP) caused by this bacterium, particularly in scenarios where the prevalence of S. aureus is below 30% 1.
  • However, it is essential to note that the diagnostic performance of Gram staining morphology is not sufficient to determine the decision to introduce an antibiotic scheme solely, and other risk factors and severity should still be considered by attending clinicians.
  • The treatment of infections caused by Gram-positive bacteria, such as S. aureus, typically involves the use of antibiotics, such as penicillins, cephalosporins, or vancomycin, with specific choices depending on susceptibility patterns and potential resistance 1.

From the Research

Gram-Positive Bacteria

  • Gram-positive bacteria are a type of bacteria that have a thick peptidoglycan cell wall, which retains the crystal violet stain used in the Gram staining procedure, causing them to appear purple under a microscope 2, 3, 4, 5, 6
  • They can form clusters or chains, and are commonly found in the environment and as part of the human microbiota 2, 3, 4, 5, 6

Treatment of Gram-Positive Infections

  • Vancomycin has been considered the standard of care for treatment of Gram-positive skin and soft-tissue infections (SSTIs), but its value has been questioned due to limitations in efficacy and tolerability and the emergence of newer MRSA-active antibacterial agents 2
  • Newer antibiotics such as linezolid, telavancin, and dalbavancin have shown promise in treating Gram-positive infections, including those caused by MRSA 2, 3, 5
  • The safety of newer antimicrobials is generally comparable to vancomycin, but some agents may be associated with more severe adverse events, such as nephrotoxicity with telavancin 2, 5

Chain and Cluster Formation

  • Some Gram-positive bacteria, such as Staphylococcus aureus, can form clusters, while others, such as Streptococcus pyogenes, can form chains 6
  • The formation of chains or clusters can affect the virulence and pathogenicity of the bacteria, as well as their ability to adhere to surfaces and evade the host immune system 6

Resistance Patterns

  • Gram-positive bacteria have developed resistance to many antibiotics, including vancomycin, making treatment of infections challenging 2, 3, 4, 5, 6
  • The emergence of vancomycin-resistant enterococci (VRE) and methicillin-resistant Staphylococcus aureus (MRSA) has led to the development of new antibiotics and treatment strategies 2, 3, 4, 5, 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.